Optimising Real-World Evidence with Big Social Data in Health & Pharma

White Paper
Optimising Real-World  Evidence with  Big Social Data in Pharma

At least 4.5 billion people worldwide were using social media in July 2021 – over double the number of users in 2015. When this is combined with other online information sources, that include online blogs, crowdsourcing platforms, search engines and video sharing solutions, the Internet comprises colossal volumes of consumer data. This pot of consumer information gold is bursting with real-world insights ripe to help improve patient care and guide business decisions. To leverage the benefits of social Real-World Evidence (RWE) and catch up with other industries already reaping the rewards of well-executed social intelligence practices, pharma companies must first recognise the value this data offers them and their stakeholders.

Get the download

Below is an excerpt of "Optimising Real-World Evidence with Big Social Data in Health & Pharma". To get your free download, and unlimited access to the whole of bizibl.com, simply log in or join free.

download

Want more like this?

Want more like this?

Insight delivered to your inbox

Keep up to date with our free email. Hand picked whitepapers and posts from our blog, as well as exclusive videos and webinar invitations keep our Users one step ahead.

By clicking 'SIGN UP', you agree to our Terms of Use and Privacy Policy

side image splash

By clicking 'SIGN UP', you agree to our Terms of Use and Privacy Policy